TipRanks
Advertisement
Advertisement
Neuromod Devices Targets Global ENT Exposure With IFOS Istanbul 2026 Presence
PremiumPrivate CompaniesNeuromod Devices Targets Global ENT Exposure With IFOS Istanbul 2026 Presence
28d ago
Neuromod Devices Ltd – Weekly Recap
Premium
Private Companies
Neuromod Devices Ltd – Weekly Recap
1M ago
Australian Clinic Expansion for Lenire Tinnitus Treatment
Premium
Private Companies
Australian Clinic Expansion for Lenire Tinnitus Treatment
1M ago
Tinnitus Therapy Device Gains Placement in 2026 Audiology Practice Guidelines
PremiumPrivate CompaniesTinnitus Therapy Device Gains Placement in 2026 Audiology Practice Guidelines
2M ago
Neuromod Devices Expands Remote Access to Lenire Tinnitus Treatment
Premium
Private Companies
Neuromod Devices Expands Remote Access to Lenire Tinnitus Treatment
2M ago
Bloomberg Coverage Elevates Visibility of Neuromod’s Lenire Tinnitus Therapy
Premium
Private Companies
Bloomberg Coverage Elevates Visibility of Neuromod’s Lenire Tinnitus Therapy
3M ago
Media Feature Highlights Growing Interest in Neuromod’s Lenire Tinnitus Therapy
PremiumPrivate CompaniesMedia Feature Highlights Growing Interest in Neuromod’s Lenire Tinnitus Therapy
4M ago
Neuromod Devices Steps Up Canadian Tinnitus Market Push With 2026 CSOHNS Presence
Premium
Private Companies
Neuromod Devices Steps Up Canadian Tinnitus Market Push With 2026 CSOHNS Presence
4M ago
Neuromod Devices Targets Canadian ENT Market Through CSOHNS 2026 Presence
Premium
Private Companies
Neuromod Devices Targets Canadian ENT Market Through CSOHNS 2026 Presence
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―